How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
To explore the implications from mandatory dietary supplement product listing provisions (as previously included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348)); to explore the role and needs of small businesses for market entry in the dietary supplement channel; to explore health savings accounts / flexible spending accounts in relation to dietary supplement products.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BRANDCO DISTRIBUTING LLC via MS. TAMI WAHL
2026 · third_quarter · Q3
Matters related to or potentially impacting the genetics and legal status of hemp (cannabis) seeds.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SKY MARKETING CORPORATION via MS. TAMI WAHL
2026 · third_quarter · Q3
Source: Senate LDA
| LIAISON GROUP ON BEHALF OF TOKKEN |
| 8 |
| 2017 |
| ASSOCIATION OF CANNABIS SPECIALISTS | 7 | 2021–2022 |
| ROCK & ASSOCIATES | 7 | 2017–2019 |
| PARRY, ROMANI, DECONCINI & SYMMS ON BEHALF OF BELMAR SELECT OUTSOURCING | 5 | 2019 |
| PARRY, ROMANI, DECONCINI & SYMMS ON BEHALF OF FAGRON | 5 | 2019 |
| PARRY, ROMANI, DECONCINI & SYMMS ON BEHALF OF OLYMPIA PHARMACY | 5 | 2019 |
| PARRY, ROMANI, DECONCINI & SYMMS ON BEHALF OF US COMPOUNDING PHARMACY | 5 | 2019 |
| AFG DISTRIBUTION, INC. | 4 | 2022 |
| LELOI AB | 4 | 2021 |
| ROCK & ASSOCIATES ON BEHALF OF PARRY, ROMANI, DECONCINI & SYMMS | 4 | 2018–2019 |
| GREEN FARMS CO, LLC | 3 | 2020–2021 |
| PARRY, ROMANI, DECONCINI & SYMMS ON BEHALF OF EMPOWER PHARMACY | 3 | 2019 |
| OSRX, INC. | 2 | 2019 |
To explore the implications from mandatory dietary supplement product listing provisions (as previously included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348)); to explore the role and needs of small businesses for market entry in the dietary supplement channel.
To explore the implications from mandatory dietary supplement product listing provisions (as previously included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348)); to explore the role and needs of small businesses for market entry in the dietary supplement channel; to explore health savings accounts / flexible spending accounts in relation to dietary supplement products.
To explore the implications from mandatory dietary supplement product listing provisions (as previously included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348)); to explore the role and needs of small businesses for market entry in the dietary supplement channel; to explore health savings accounts / flexible spending accounts in relation to dietary supplement products.
To clarify the regulatory uncertainty of the hemp-derived cannabidiol ingredient; to explore the implications from mandatory dietary supplement product listing provisions (as previoulsy included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348)); to explore the role and needs of small businesses for market entry.
To clarify the regulatory uncertainty of the hemp-derived cannabidiol (CBD) ingredient; and to explore the implications from the mandatory dietary supplement product listing provisions as included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348).
To clarify the regulatory uncertainty of the hemp-derived cannabidiol (CBD) ingredient; and to explore the implications from the mandatory dietary supplement product listing provisions as included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348).
To clarify the regulatory uncertainty of the hemp-derived cannabidiol (CBD) ingredient; and to explore the implications from the mandatory dietary supplement product listing provisions as included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348).
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
Client: TRADITIONAL MEDICINALS · Firm: MS. TAMI WAHL
To advance HR5587, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
Client: TRADITIONAL MEDICINALS · Firm: MS. TAMI WAHL
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
Client: TRADITIONAL MEDICINALS · Firm: MS. TAMI WAHL
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
Client: TRADITIONAL MEDICINALS · Firm: MS. TAMI WAHL
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
Client: TRADITIONAL MEDICINALS · Firm: MS. TAMI WAHL
To advance HR5587, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
Client: TRADITIONAL MEDICINALS · Firm: MS. TAMI WAHL
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
Client: TRADITIONAL MEDICINALS · Firm: MS. TAMI WAHL
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
Client: TRADITIONAL MEDICINALS · Firm: MS. TAMI WAHL
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
Client: TRADITIONAL MEDICINALS · Firm: MS. TAMI WAHL
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
Client: TRADITIONAL MEDICINALS · Firm: MS. TAMI WAHL
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: MS. TAMI WAHL
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: MS. TAMI WAHL
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: MS. TAMI WAHL
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: MS. TAMI WAHL
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: MS. TAMI WAHL
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: MS. TAMI WAHL
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: MS. TAMI WAHL
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: MS. TAMI WAHL
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Ending Federal Marijuana Prohibition Act of 2017
Client: LIAISON GROUP ON BEHALF OF TOKKEN · Firm: MS. TAMI WAHL
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Ending Federal Marijuana Prohibition Act of 2017
Client: LIAISON GROUP ON BEHALF OF TOKKEN · Firm: MS. TAMI WAHL
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Ending Federal Marijuana Prohibition Act of 2017
Client: LIAISON GROUP ON BEHALF OF TOKKEN · Firm: MS. TAMI WAHL
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Ending Federal Marijuana Prohibition Act of 2017
Client: LIAISON GROUP ON BEHALF OF TOKKEN · Firm: MS. TAMI WAHL
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Ending Federal Marijuana Prohibition Act of 2017
Client: LIAISON GROUP ON BEHALF OF TOKKEN · Firm: MS. TAMI WAHL
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Small Business Tax Equity Act of 2017
Client: LIAISON GROUP ON BEHALF OF TOKKEN · Firm: MS. TAMI WAHL
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Small Business Tax Equity Act of 2017
Client: LIAISON GROUP ON BEHALF OF TOKKEN · Firm: MS. TAMI WAHL
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Small Business Tax Equity Act of 2017
Client: LIAISON GROUP ON BEHALF OF TOKKEN · Firm: MS. TAMI WAHL
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Small Business Tax Equity Act of 2017
Client: LIAISON GROUP ON BEHALF OF TOKKEN · Firm: MS. TAMI WAHL
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Small Business Tax Equity Act of 2017
Client: LIAISON GROUP ON BEHALF OF TOKKEN · Firm: MS. TAMI WAHL
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
To authorize the expansion of an existing hydroelectric project, and for other purposes.
Client: LIAISON GROUP ON BEHALF OF TOKKEN · Firm: MS. TAMI WAHL
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
To authorize the expansion of an existing hydroelectric project, and for other purposes.
Client: LIAISON GROUP ON BEHALF OF TOKKEN · Firm: MS. TAMI WAHL
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
To authorize the expansion of an existing hydroelectric project, and for other purposes.
Client: LIAISON GROUP ON BEHALF OF TOKKEN · Firm: MS. TAMI WAHL
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
To authorize the expansion of an existing hydroelectric project, and for other purposes.
Client: LIAISON GROUP ON BEHALF OF TOKKEN · Firm: MS. TAMI WAHL
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
To authorize the expansion of an existing hydroelectric project, and for other purposes.
Client: LIAISON GROUP ON BEHALF OF TOKKEN · Firm: MS. TAMI WAHL
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Legislation to facilitate the capacity of traditional banking institutions to service state-authorized Cannabis businesses, S1152 / HR2215, 'Secure and Fair Enforcement Banking Act of 2017.'
Legislation to facilitate the capacity of traditional banking institutions to service state-authorized Cannabis businesses, S1152 / HR2215, 'Secure and Fair Enforcement Banking Act of 2017.'
Legislation to facilitate the capacity of traditional banking institutions to service state-authorized Cannabis businesses, S1152 | HR2215, 'Secure and Fair Enforcement Banking Act of 2017.'
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Legislation to facilitate the capacity of traditional banking institutions to service state-authorized Cannabis businesses, S1152 / HR2215, 'Secure and Fair Enforcement Banking Act of 2017.'
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Legislation to facilitate the capacity of traditional banking institutions to service state-authorized Cannabis businesses, S1152 / HR2215, 'Secure and Fair Enforcement Banking Act of 2017.'
Legislation to facilitate the capacity of traditional banking institutions to service state-authorized Cannabis businesses, S1152 | HR2215, 'Secure and Fair Enforcement Banking Act of 2017.'
Legislation to facilitate the capacity of traditional banking institutions to service state-authorized Cannabis businesses, S1152 / HR2215, 'Secure and Fair Enforcement Banking Act of 2017.'
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: MS. TAMI WAHL
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: MS. TAMI WAHL
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Legislation to facilitate the capacity of traditional banking institutions to service state-authorized Cannabis businesses, S1152 / HR2215, 'Secure and Fair Enforcement Banking Act of 2017.'
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Legislation to facilitate the capacity of traditional banking institutions to service state-authorized Cannabis businesses, S1152 / HR2215, 'Secure and Fair Enforcement Banking Act of 2017.'
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Legislation to facilitate the capacity of traditional banking institutions to service state-authorized Cannabis businesses, S1152 / HR2215, 'Secure and Fair Enforcement Banking Act of 2017.'
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Legislation to facilitate the capacity of traditional banking institutions to service state-authorized Cannabis businesses, S1152 | HR2215, 'Secure and Fair Enforcement Banking Act of 2017.'
Legislation to facilitate the capacity of traditional banking institutions to service state-authorized Cannabis businesses, S1152 / HR2215, 'Secure and Fair Enforcement Banking Act of 2017.'
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Legislation to facilitate the capacity of traditional banking institutions to service state-authorized Cannabis businesses, S1152 | HR2215, 'Secure and Fair Enforcement Banking Act of 2017.'
Legislation to facilitate the capacity of traditional banking institutions to service state-authorized Cannabis businesses, S1152 / HR2215, 'Secure and Fair Enforcement Banking Act of 2017.'
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Small Business Tax Equity Act of 2017
Client: LIAISON GROUP ON BEHALF OF TOKKEN · Firm: MS. TAMI WAHL
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Small Business Tax Equity Act of 2017
Client: LIAISON GROUP ON BEHALF OF TOKKEN · Firm: MS. TAMI WAHL
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Small Business Tax Equity Act of 2017
Client: LIAISON GROUP ON BEHALF OF TOKKEN · Firm: MS. TAMI WAHL
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Small Business Tax Equity Act of 2017
Client: LIAISON GROUP ON BEHALF OF TOKKEN · Firm: MS. TAMI WAHL
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Small Business Tax Equity Act of 2017
Client: LIAISON GROUP ON BEHALF OF TOKKEN · Firm: MS. TAMI WAHL
Provide legislative solutions to: protect state-enacted Cannabis programs (e.g., S1374/HR220, CARERS); allow traditional banking institutions to provide financial services to state-authorized Cannabis businesses (e.g., S1152/HR2215, SAFE); create parity for state-authorized Cannabis businesses with other legally operating businesses within respective state (e.g., S777/HR1810 (IRC - 280E), HR1227 (descheduling)).
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
TCM ENTERPRISES LLC via MS. TAMI WAHL
2026 · third_quarter · Q3
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021); to monitor legislation that may impact non-tobacco devices and products.
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021); to monitor legislation that may impact non-tobacco devices and products.
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRADITIONAL MEDICINALS via MS. TAMI WAHL
2026 · third_quarter · Q3
Monitoring the regulatory environment for, i) the dietary supplement category and market entry thresholds for same, ii) domestic manufacturing and tariff implications.
Monitoring / mitigating tariff implications on components and equipment not available stateside for domestic manufacturing operations.
Monitoring the regulatory environment for the dietary supplement category with domestic manufacturing capabilities and tariff implications.
Explore the role of small businesses i) in the dietary supplement category and needs of same for market entry, and ii) in domestic manufacturing and potential tariff implications.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), SENATE, U.S. Trade Representative (USTR), White House Office
BRANDCO DISTRIBUTING LLC via MS. TAMI WAHL
2026 · second_quarter · Q2
Matters related to or potentially impacting the genetics and legal status of hemp (cannabis) seeds.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SKY MARKETING CORPORATION via MS. TAMI WAHL
2026 · second_quarter · Q2
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
TCM ENTERPRISES LLC via MS. TAMI WAHL
2026 · second_quarter · Q2
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021); to monitor legislation that may impact non-tobacco devices and products.
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
TRADITIONAL MEDICINALS via MS. TAMI WAHL
2026 · second_quarter · Q2
Monitoring the regulatory environment for the dietary supplement category with domestic manufacturing capabilities and tariff implications.
Explore the role of small businesses i) in the dietary supplement category and needs of same for market entry, and ii) in domestic manufacturing and potential tariff implications.
Monitoring / mitigating tariff implications on components and equipment not available stateside for domestic manufacturing operations.
BRANDCO DISTRIBUTING LLC via MS. TAMI WAHL
2026 · first_quarter · Q1
Matters related to or potentially impacting the genetics and legal status of hemp (cannabis) seeds.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SKY MARKETING CORPORATION via MS. TAMI WAHL
2026 · first_quarter · Q1
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
TCM ENTERPRISES LLC via MS. TAMI WAHL
2026 · first_quarter · Q1
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021); to monitor legislation that may impact non-tobacco devices and products.
TRADITIONAL MEDICINALS via MS. TAMI WAHL
2026 · first_quarter · Q1
Monitoring / mitigating tariff implications on components and equipment not available stateside for domestic manufacturing operations.
Monitoring the regulatory environment for the dietary supplement category with domestic manufacturing capabilities and tariff implications.
Monitoring the regulatory environment for, i) the dietary supplement category and market entry thresholds for same, ii) domestic manufacturing and tariff implications.
BRANDCO DISTRIBUTING LLC via MS. TAMI WAHL
2025 · fourth_quarter · Q4
Matters related to or potentially impacting the genetics and legal status of hemp (cannabis) seeds.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SKY MARKETING CORPORATION via MS. TAMI WAHL
2025 · fourth_quarter · Q4
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
TCM ENTERPRISES LLC via MS. TAMI WAHL
2025 · fourth_quarter · Q4
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021); to monitor legislation that may impact non-tobacco devices and products.
TRADITIONAL MEDICINALS via MS. TAMI WAHL
2025 · fourth_quarter · Q4
Monitoring the regulatory environment for, i) the dietary supplement category and market entry thresholds for same, ii) domestic manufacturing and tariff implications.
Explore the role of small businesses i) in the dietary supplement category and needs of same for market entry, and ii) in domestic manufacturing and potential tariff implications.
Monitoring the regulatory environment for the dietary supplement category with domestic manufacturing capabilities and tariff implications.
TCM ENTERPRISES LLC via MS. TAMI WAHL
2025 · third_quarter · Q3
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021); to monitor legislation that may impact non-tobacco devices and products.
TRADITIONAL MEDICINALS via MS. TAMI WAHL
2025 · third_quarter · Q3
Monitoring the regulatory environment for, i) the dietary supplement category and market entry thresholds for same, ii) domestic manufacturing and tariff implications.
Explore the role of small businesses i) in the dietary supplement category and needs of same for market entry, and ii) in domestic manufacturing and potential tariff implications.
Monitoring the regulatory environment for the dietary supplement category with domestic manufacturing capabilities and tariff implications.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), SENATE, White House Office
SKY MARKETING CORPORATION via MS. TAMI WAHL
2025 · third_quarter · Q3
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
BRANDCO DISTRIBUTING LLC via MS. TAMI WAHL
2025 · third_quarter · Q3
Matters related to or potentially impacting the genetics and legal status of hemp (cannabis) seeds.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JUST AMAZING CREATIONS LLC via MS. TAMI WAHL
2025 · third_quarter · 3T
Matters related to or potentially impacting the genetics and legal status of hemp (cannabis) seeds, hemp products, and other natural botanical products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JUST AMAZING CREATIONS LLC via MS. TAMI WAHL
2025 · second_quarter · Q2
Matters related to or potentially impacting the genetics and legal status of hemp (cannabis) seeds, hemp products, and other natural botanical products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRANDCO DISTRIBUTING LLC via MS. TAMI WAHL
2025 · second_quarter · Q2
Matters related to or potentially impacting the genetics and legal status of hemp (cannabis) seeds.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SKY MARKETING CORPORATION via MS. TAMI WAHL
2025 · second_quarter · Q2
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TCM ENTERPRISES LLC via MS. TAMI WAHL
2025 · second_quarter · Q2
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
TRADITIONAL MEDICINALS via MS. TAMI WAHL
2025 · second_quarter · Q2
Monitoring the regulatory environment for, i) the dietary supplement category and market entry thresholds for same, ii) domestic manufacturing and tariff implications.
Explore the role of small businesses i) in the dietary supplement category and needs of same for market entry, and ii) in domestic manufacturing and potential tariff implications.
Monitoring the regulatory environment for the dietary supplement category with domestic manufacturing capabilities and tariff implications.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), SENATE, White House Office
MOOD PRODUCT GROUP LLC via MS. TAMI WAHL
2025 · second_quarter · 2T
Matters related to the U.S. hemp program and finished consumer good products that contain hemp and hemp-derived constituents.
Matters related to the U.S. hemp program and finished consumer good products that contain hemp and hemp-derived constituents.
Matters related to the U.S. hemp program and finished consumer good products that contain hemp and hemp-derived constituents.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JUST AMAZING CREATIONS LLC via MS. TAMI WAHL
2025 · first_quarter · Q1
Matters related to or potentially impacting the genetics and legal status of hemp (cannabis) seeds, hemp products, and other natural botanical products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRANDCO DISTRIBUTING LLC via MS. TAMI WAHL
2025 · first_quarter · Q1
Matters related to or potentially impacting the genetics and legal status of hemp (cannabis) seeds.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MOOD PRODUCT GROUP LLC via MS. TAMI WAHL
2025 · first_quarter · Q1
Matters related to the U.S. hemp program and finished consumer good products that contain hemp and hemp-derived constituents.
Matters related to the U.S. hemp program and finished consumer good products that contain hemp and hemp-derived constituents.
Matters related to the U.S. hemp program and finished consumer good products that contain hemp and hemp-derived constituents.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SKY MARKETING CORPORATION via MS. TAMI WAHL
2025 · first_quarter · Q1
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TCM ENTERPRISES LLC via MS. TAMI WAHL
2025 · first_quarter · Q1
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
TRADITIONAL MEDICINALS via MS. TAMI WAHL
2025 · first_quarter · Q1
Monitoring the regulatory environment for the dietary supplement category and market entry thresholds for same.
Explore the role of small businesses in the dietary supplement category and needs of same for market entry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
JUST AMAZING CREATIONS LLC via MS. TAMI WAHL
2024 · fourth_quarter · Q4
Matters related to or potentially impacting the genetics and legal status of hemp (cannabis) seeds, hemp products, and other natural botanical products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRANDCO DISTRIBUTING LLC via MS. TAMI WAHL
2024 · fourth_quarter · Q4
Matters related to or potentially impacting the genetics and legal status of hemp (cannabis) seeds.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MOOD PRODUCT GROUP LLC via MS. TAMI WAHL
2024 · fourth_quarter · Q4
Matters related to market access for finished consumer good products that contain hemp and hemp-derived constituents.
Matters related to market access for finished consumer good products that contain hemp and hemp-derived constituents.
Matters related to the U.S. hemp program and finished consumer good products that contain hemp and hemp-derived constituents.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SKY MARKETING CORPORATION via MS. TAMI WAHL
2024 · fourth_quarter · Q4
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TCM ENTERPRISES LLC via MS. TAMI WAHL
2024 · fourth_quarter · Q4
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
TRADITIONAL MEDICINALS via MS. TAMI WAHL
2024 · fourth_quarter · Q4
Monitoring the regulatory environment for the dietary supplement category and market entry thresholds for same.
To explore the role of small businesses and needs of same for market entry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
JUST AMAZING CREATIONS LLC via MS. TAMI WAHL
2024 · third_quarter · Q3
Matters related to or potentially impacting the genetics and legal status of hemp (cannabis) seeds, hemp products, and other natural botanical products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRANDCO DISTRIBUTING LLC via MS. TAMI WAHL
2024 · third_quarter · Q3
Matters related to or potentially impacting the genetics and legal status of hemp (cannabis) seeds.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MOOD PRODUCT GROUP LLC via MS. TAMI WAHL
2024 · third_quarter · Q3
Matters related to market access for finished consumer good products that contain hemp and hemp-derived constituents.
Matters related to the U.S. hemp program and finished consumer good products that contain hemp and hemp-derived constituents.
Matters related to market access for finished consumer good products that contain hemp and hemp-derived constituents.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SKY MARKETING CORPORATION via MS. TAMI WAHL
2024 · third_quarter · Q3
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TCM ENTERPRISES LLC via MS. TAMI WAHL
2024 · third_quarter · Q3
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
TRADITIONAL MEDICINALS via MS. TAMI WAHL
2024 · third_quarter · Q3
To explore the role of small businesses and needs of same for market entry.
Monitoring the regulatory environment for the dietary supplement category and market entry thresholds for same.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
JUST AMAZING CREATIONS LLC via MS. TAMI WAHL
2024 · second_quarter · Q2
Matters related to or potentially impacting the genetics and legal status of hemp (cannabis) seeds, hemp products, and other natural botanical products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRANDCO DISTRIBUTING LLC via MS. TAMI WAHL
2024 · second_quarter · Q2
Matters related to or potentially impacting the genetics and legal status of hemp (cannabis) seeds.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MOOD PRODUCT GROUP LLC via MS. TAMI WAHL
2024 · second_quarter · Q2
Matters related to market access for finished consumer good products that contain hemp and hemp-derived constituents.
Matters related to market access for finished consumer good products that contain hemp and hemp-derived constituents.
Matters related to the U.S. hemp program and finished consumer good products that contain hemp and hemp-derived constituents.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SKY MARKETING CORPORATION via MS. TAMI WAHL
2024 · second_quarter · Q2
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TCM ENTERPRISES LLC via MS. TAMI WAHL
2024 · second_quarter · Q2
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
TRADITIONAL MEDICINALS via MS. TAMI WAHL
2024 · second_quarter · Q2
To explore the role of small businesses and needs of same for market entry.
Monitoring the regulatory environment for the dietary supplement category and market entry thresholds for same.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
JUST AMAZING CREATIONS LLC via MS. TAMI WAHL
2024 · first_quarter · Q1
Matters related to or potentially impacting the genetics and legal status of hemp (cannabis) seeds, hemp products, and other natural botanical products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRANDCO DISTRIBUTING LLC via MS. TAMI WAHL
2024 · first_quarter · Q1
Matters related to or potentially impacting the genetics and legal status of hemp (cannabis) seeds.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MOOD PRODUCT GROUP LLC via MS. TAMI WAHL
2024 · first_quarter · Q1
Matters related to market access for finished consumer good products that contain hemp and hemp-derived constituents.
Matters related to market access for finished consumer good products that contain hemp and hemp-derived constituents.
Matters related to the U.S. hemp program and finished consumer good products that contain hemp and hemp-derived constituents.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SKY MARKETING CORPORATION via MS. TAMI WAHL
2024 · first_quarter · Q1
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TCM ENTERPRISES LLC via MS. TAMI WAHL
2024 · first_quarter · Q1
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
TRADITIONAL MEDICINALS via MS. TAMI WAHL
2024 · first_quarter · Q1
To explore the role of small businesses and needs of same for market entry.
To explore the implications from mandatory dietary supplement product listing provisions (as previously included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348)); to explore the role and needs of small businesses for market entry in the dietary supplement channel; to explore health savings accounts / flexible spending accounts in relation to dietary supplement products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
JUST AMAZING CREATIONS LLC via MS. TAMI WAHL
2023 · fourth_quarter · RR
Matters related to or potentially impacting the genetics and legal status of hemp (cannabis) seeds, hemp products, and other natural botanical products.
BRANDCO DISTRIBUTING LLC via MS. TAMI WAHL
2023 · fourth_quarter · RR
Matters related to or potentially impacting the genetics and legal status of hemp (cannabis) seeds.
TCM ENTERPRISES LLC via MS. TAMI WAHL
2023 · fourth_quarter · Q4
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
MOOD PRODUCT GROUP LLC via MS. TAMI WAHL
2023 · fourth_quarter · Q4
Matters related to the U.S. hemp program and finished consumer good products that contain hemp and hemp-derived constituents.
Matters related to market access for finished consumer good products that contain hemp and hemp-derived constituents.
Matters related to market access for finished consumer good products that contain hemp and hemp-derived constituents.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SKY MARKETING CORPORATION via MS. TAMI WAHL
2023 · fourth_quarter · Q4
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRADITIONAL MEDICINALS via MS. TAMI WAHL
2023 · fourth_quarter · Q4
To explore the role of small businesses and needs of same for market entry.
To explore the implications from mandatory dietary supplement product listing provisions (as previously included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348)); to explore the role and needs of small businesses for market entry in the dietary supplement channel; to explore health savings accounts / flexible spending accounts in relation to dietary supplement products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MOOD PRODUCT GROUP LLC via MS. TAMI WAHL
2023 · third_quarter · Q3
Matters related to the U.S. hemp program and finished consumer good products that contain hemp and hemp-derived constituents.
Matters related to market access for finished consumer good products that contain hemp and hemp-derived constituents.
Matters related to market access for finished consumer good products that contain hemp and hemp-derived constituents.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
SKY MARKETING CORPORATION via MS. TAMI WAHL
2023 · third_quarter · Q3
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
TCM ENTERPRISES LLC via MS. TAMI WAHL
2023 · third_quarter · Q3
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
TRADITIONAL MEDICINALS via MS. TAMI WAHL
2023 · third_quarter · Q3
To explore the implications from mandatory dietary supplement product listing provisions (as previously included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348)); to explore the role and needs of small businesses for market entry in the dietary supplement channel; to explore health savings accounts / flexible spending accounts in relation to dietary supplement products.
To explore the role of small businesses and needs of same for market entry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
MOOD PRODUCT GROUP LLC via MS. TAMI WAHL
2023 · second_quarter · Q2
Matters related to market access for finished consumer good products that contain hemp and hemp-derived constituents.
Matters related to market access for finished consumer good products that contain hemp and hemp-derived constituents.
Matters related to market access for finished consumer good products that contain hemp and hemp-derived constituents.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SKY MARKETING CORPORATION via MS. TAMI WAHL
2023 · second_quarter · Q2
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
TCM ENTERPRISES LLC via MS. TAMI WAHL
2023 · second_quarter · Q2
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
TRADITIONAL MEDICINALS via MS. TAMI WAHL
2023 · second_quarter · Q2
To explore the role of small businesses and needs of same for market entry.
To explore the implications from mandatory dietary supplement product listing provisions (as previously included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348)); to explore the role and needs of small businesses for market entry in the dietary supplement channel.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
MOOD PRODUCT GROUP LLC via MS. TAMI WAHL
2023 · second_quarter · RR
Matters related to market access for finished products containing hemp and hemp-derived constituents.
Matters related to market access for finished products containing hemp and hemp-derived constituents.
SKY MARKETING CORPORATION via MS. TAMI WAHL
2023 · first_quarter · Q1
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoid-containing products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
TCM ENTERPRISES LLC via MS. TAMI WAHL
2023 · first_quarter · Q1
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
TRADITIONAL MEDICINALS via MS. TAMI WAHL
2023 · first_quarter · Q1
To clarify the regulatory uncertainty of the hemp-derived cannabidiol ingredient; to explore the implications from mandatory dietary supplement product listing provisions (as previoulsy included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348)); to explore the role and needs of small businesses for market entry.
To clarify the regulatory uncertainty of the hemp-derived cannabidiol ingredient.
To explore the role of small businesses and needs of same for market entry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
SKY MARKETING CORPORATION via MS. TAMI WAHL
2022 · fourth_quarter · Q4
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoids and minor cannabinoids.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoids and minor cannabinoids.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoids and minor cannabinoids.
Filing targets: HOUSE OF REPRESENTATIVES, Small Business Administration (SBA)
TCM ENTERPRISES LLC via MS. TAMI WAHL
2022 · fourth_quarter · Q4
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
TRADITIONAL MEDICINALS via MS. TAMI WAHL
2022 · fourth_quarter · Q4
To clarify the regulatory uncertainty of the hemp-derived cannabidiol (CBD) ingredient; and to explore the implications from the mandatory dietary supplement product listing provisions as included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348).
To clarify the regulatory uncertainty of the hemp-derived cannabidiol (CBD) ingredient.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
AFG DISTRIBUTION, INC. via MS. TAMI WAHL
2022 · third_quarter · 3T
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco products, as currently defined in the United States Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco products, as currently defined in the United States Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco products, as currently defined in the United States Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
TRADITIONAL MEDICINALS via MS. TAMI WAHL
2022 · third_quarter · Q3
To clarify the regulatory uncertainty of the hemp-derived cannabidiol (CBD) ingredient; and to explore the implications from the mandatory dietary supplement product listing provisions as included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348).
To clarify the regulatory uncertainty of the hemp-derived cannabidiol (CBD) ingredient.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
TCM ENTERPRISES LLC via MS. TAMI WAHL
2022 · third_quarter · Q3
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
SKY MARKETING CORPORATION via MS. TAMI WAHL
2022 · third_quarter · Q3
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoids and minor cannabinoids.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoids and minor cannabinoids.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoids and minor cannabinoids.
Filing targets: HOUSE OF REPRESENTATIVES, Small Business Administration (SBA)
SKY MARKETING CORPORATION via MS. TAMI WAHL
2022 · second_quarter · Q2
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoids and minor cannabinoids.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoids and minor cannabinoids.
Ensuring the market remains open for U.S. grown hemp-containing finished goods, to include hemp cannabinoids and minor cannabinoids.
Filing targets: HOUSE OF REPRESENTATIVES, Small Business Administration (SBA)
AFG DISTRIBUTION, INC. via MS. TAMI WAHL
2022 · second_quarter · Q2
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco products, as currently defined in the United States Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco products, as currently defined in the United States Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco products, as currently defined in the United States Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
TCM ENTERPRISES LLC via MS. TAMI WAHL
2022 · second_quarter · Q2
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
TRADITIONAL MEDICINALS via MS. TAMI WAHL
2022 · second_quarter · Q2
To clarify the regulatory uncertainty of the hemp-derived cannabidiol (CBD) ingredient.
To clarify the regulatory uncertainty of the hemp-derived cannabidiol (CBD) ingredient; and to explore the implications from the mandatory dietary supplement product listing provisions as included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
SKY MARKETING CORPORATION via MS. TAMI WAHL
2022 · second_quarter · RR
Issues related to market access for the hemp plant and hemp-derived constituents.
Issues related to market access for the hemp plant and hemp-derived constituents.
ASSOCIATION OF CANNABIS SPECIALISTS via MS. TAMI WAHL
2022 · second_quarter · 2T
Ensuring a medical cannabis paradigm is included in any comprehensive federal reform legislation and that such paradigm is subject to appropriate standards to allow best possible patient outcomes.
Ensuring a medical cannabis paradigm is included in any comprehensive federal reform legislation and that such paradigm is subject to appropriate standards to allow best possible patient outcomes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AFG DISTRIBUTION, INC. via MS. TAMI WAHL
2022 · first_quarter · Q1
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco products, as currently defined in the United States Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco products, as currently defined in the United States Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco products, as currently defined in the United States Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
TCM ENTERPRISES LLC via MS. TAMI WAHL
2022 · first_quarter · Q1
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
ASSOCIATION OF CANNABIS SPECIALISTS via MS. TAMI WAHL
2022 · first_quarter · Q1
Ensuring a medical cannabis paradigm is included in any comprehensive federal reform legislation and that such paradigm is subject to appropriate standards to allow best possible patient outcomes.
Ensuring a medical cannabis paradigm is included in any comprehensive federal reform legislation and that such paradigm is subject to appropriate standards to allow best possible patient outcomes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRADITIONAL MEDICINALS via MS. TAMI WAHL
2022 · first_quarter · Q1
To clarify the regulatory uncertainty of the hemp-derived cannabidiol (CBD) ingredient.
To clarify the regulatory uncertainty of the hemp-derived cannabidiol (CBD) ingredient.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
AFG DISTRIBUTION, INC. via MS. TAMI WAHL
2022 · first_quarter · RR
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco products, as currently defined in the United States Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco products, as currently defined in the United States Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco products, as currently defined in the United States Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
2021 · fourth_quarter · 4T
Addressing the barriers to the digital marketplace that are imposed on innovators advancing women's wellness and lifestyle products and platforms.
Addressing the barriers to the digital marketplace that are imposed on innovators advancing women's wellness and lifestyle products and platforms.
Addressing the barriers to the digital marketplace that are imposed on innovators advancing women's wellness and lifestyle products and platforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TCM ENTERPRISES LLC via MS. TAMI WAHL
2021 · fourth_quarter · Q4
To address the scope of the mail prohibition under the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the mail prohibition under the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
ASSOCIATION OF CANNABIS SPECIALISTS via MS. TAMI WAHL
2021 · fourth_quarter · Q4
Ensuring a medical cannabis paradigm is included in any comprehensive federal reform legislation and that such paradigm is subject to appropriate standards to allow best possible patient outcomes.
Ensuring a medical cannabis paradigm is included in any comprehensive federal reform legislation and that such paradigm is subject to appropriate standards to allow best possible patient outcomes.
Filing targets: Office of Natl Drug Control Policy (NDCP), SENATE
TRADITIONAL MEDICINALS via MS. TAMI WAHL
2021 · fourth_quarter · Q4
To clarify the regulatory uncertainty of the hemp-derived cannabidiol (CBD) ingredient.
To clarify the regulatory uncertainty of the hemp-derived cannabidiol (CBD) ingredient.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
2021 · third_quarter · Q3
Addressing the barriers to the digital marketplace that are imposed on innovators advancing women's wellness and lifestyle products and platforms.
Addressing the barriers to the digital marketplace that are imposed on innovators advancing women's wellness and lifestyle products and platforms.
Addressing the barriers to the digital marketplace that are imposed on innovators advancing women's wellness and lifestyle products and platforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TCM ENTERPRISES LLC via MS. TAMI WAHL
2021 · third_quarter · Q3
To address the scope of the mail prohibition under the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, as currently being explored in the U.S. Postal Service (USPS) Proposed Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 10218 (19.Feb.2021).
To address the scope of the mail prohibition under the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, as currently being explored in the U.S. Postal Service (USPS) Proposed Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 10218 (19.Feb.2021).
ASSOCIATION OF CANNABIS SPECIALISTS via MS. TAMI WAHL
2021 · third_quarter · Q3
Ensuring a medical cannabis paradigm is included in any comprehensive federal reform legislation and that such paradigm is subject to appropriate standards to allow best possible patient outcomes.
Ensuring a medical cannabis paradigm is included in any comprehensive federal reform legislation and that such paradigm is subject to appropriate standards to allow best possible patient outcomes.
Filing targets: SENATE
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021); to monitor legislation that may impact non-tobacco devices and products.
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Monitoring the regulatory environment for, i) the dietary supplement category and market entry thresholds for same, ii) domestic manufacturing and tariff implications.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), SENATE, U.S. Trade Representative (USTR), White House Office
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021); to monitor legislation that may impact non-tobacco devices and products.
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Explore the role of small businesses i) in the dietary supplement category and needs of same for market entry, and ii) in domestic manufacturing and potential tariff implications.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), SENATE, U.S. Trade Representative (USTR), White House Office
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021); to monitor legislation that may impact non-tobacco devices and products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Monitoring / mitigating tariff implications on components and equipment not available stateside for domestic manufacturing operations.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), SENATE, U.S. Trade Representative (USTR), White House Office
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
To address the scope of the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021); to monitor legislation that may impact non-tobacco devices and products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
To address the scope of the mail prohibition under the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, and as addressed in the ensuing U.S. Postal Service (USPS) Final Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 58398 (21.Oct.2021).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), U.S. Postal Service (USPS)
To address the scope of the mail prohibition under the 'Preventing Online Sales of E-Cigarettes to Children Act' in relation to non-tobacco devices and products, as currently being explored in the U.S. Postal Service (USPS) Proposed Rule on the Treatment of E-Cigarettes in the Mail, 86 Fed. Reg. 10218 (19.Feb.2021).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), U.S. Postal Service (USPS)